UBREDOL Trademark
Trademark Overview
On Wednesday, May 29, 2024, a trademark application was filed for UBREDOL with the United States Patent and Trademark Office. The USPTO has given the UBREDOL trademark a serial number of 98575080. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, December 11, 2024. This trademark is owned by Pharmadel, LLC. The UBREDOL trademark is filed in the Pharmaceutical Products category with the following description:
Topical analgesics
General Information
| Serial Number | 98575080 |
| Word Mark | UBREDOL |
| Filing Date | Wednesday, May 29, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Wednesday, December 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Topical analgesics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, January 1, 2024 |
| First Use In Commerce Date | Monday, January 1, 2024 |
Trademark Owner History
| Party Name | Pharmadel, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New Castle, DE 19720 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 29, 2024 | NEW APPLICATION ENTERED |
| Saturday, August 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 11, 2024 | ASSIGNED TO EXAMINER |
